SEARCH

SEARCH BY CITATION

References

  • 1
    Addington WW (1979) Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest 76 (Suppl.),S741S743.
  • 2
    Annas GJ (1993) Control of tuberculosis – the law and the public's health. New England Journal of Medicine 328 , 585588.
  • 3
    Bailey WC & Sbarbaro JA (1988) Controversies in pulmonary medicine. All patients should receive directly observed therapy in tuberculosis. American Review of Respiratory Disease 138 , 10751076.
  • 4
    Balasubramanian VN, Oommen K & Samuel R (2000) DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India. International Journal of Tuberculosis and Lung Disease 4 , 409413.
  • 5
    Bayer R, Stayton C, Desvarieux M et al. (1998) Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary? American Journal of Public Health 88 , 10521058.
  • 6
    Fujiwara PI, Larkin C & Frieden TR (1997) Directly observed therapy in New York City. History, implementation, results, and challenges. Clinics in Chest Medicine 18 , 135148.
  • 7
    Heymann SJ, Sell R & Brewer TF (1998) The influence of program acceptability on the effectiveness of public health policy: a study of directly observed therapy for tuberculosis. American Journal of Public Health 88 , 442445.
  • 8
    Hosmer DW Jr & Lemeshow S (2000) Assessing the Fit of the Model. In: Applied Logistic Regression 2nd edn (eds NAC Cressie, NI Fisher, IM Johnstone, P Kamolratanakul, H Sawert, S Lert et al.) John Wiley & Sons, New York, pp. 143–202.
  • 9
    Kamolratanakul P, Sawert H, Lertmaharit S et al. (1999) Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93 , 552557.
  • 10
    Kleinbaum DG (1994) Maximum Likelihood Techniques: An Overview. In: Logistic Regression. A Self-Learning Text. (Series eds K Dietz, M Gail, K Krickeberg & B Singer) Springer Verlag, New York, pp. 101–124.
  • 11
    Maher D, Chaulet P, Spinaci S & Harries A (1997) Treatment of Tuberculosis. Guidelines for National Programmes Global Tuberculosis Programme, World Health Organization, WHO/TB/97.220 2nd edn. Stabilimento Tipografico Ferrero s.r.l., Romanno Canavese (TO).
  • 12
    Miettinen OS (1976) Stratification by a multivariate confounder score. American Journal of Epidemiology 104 , 609620.
  • 13
    Ministry of Public Health Thailand (1998) Guidelines for National Tuberculosis Control. Ministry of Public Health, Bangkok.
  • 14
    Ministry of Public Health Thailand & World Health Organization (1995) The External Review of the National Tuberculosis Programme, Thailand 18–29 June 1995. WHO, Geneva.
  • 15
    Ministry of Public Health Thailand & World Health Organization (1999) Second Review of the National Tuberculosis Programme in Thailand. WHO/CDS/TB/99.273. WHO, Geneva.
  • 16
    Payanandana V, Kladphuang B, Somsong W & Jittimanee S (1999) Battle Against TB. National Tuberculosis Programme, Thailand, 1999. Tuberculosis Division, Department of Communicable Disease Control, Ministry of Public Health, Bangkok.
  • 17
    Salomon N, Perlman DC, Rubenstein A et al. (1997) Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program. International Journal of Tuberculosis and Lung Disease 1 , 397404.
  • 18
    StataCorp (1999) Stata Statistical Software: Release 6.0. Stata Corporation, College Station.
  • 19
    The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994–1997 (1997) Anti-Tuberculosis Drug Resistance in the World. WHO/TB/97.229. WHO, Geneva.
  • 20
    US Department of Health and Human Services (1994) Improving Patient Adherence to Tuberculosis Treatment. Public Health Service, Centers for Disease Control and Prevention, National Center for Prevention Services, Division of Tuberculosis Elimination, Georgia.
  • 21
    Volmink J, Matchaba P & Garner P (2000) Directly observed therapy and treatment adherence. Lancet 355 , 13451350.
  • 22
    Walley JD, Khan AM, Newell JN & Khan MH (2001) Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 357 , 664669.
  • 23
    Weis SE (1997) Universal directly observed therapy. A treatment strategy for tuberculosis. Clinics in Chest Medicine 18 , 155163.
  • 24
    World Health Organization (1994) TB A Global Emergency: New Attention to an Old Disease. WHO Report on the TB Epidemic 1994. WHO/TB/94.177. WHO, Geneva.
  • 25
    World Health Organization (1995) Stop TB at the Source. WHO Report on the Tuberculosis Epidemic, 1995. WHO/TB/95.183. WHO, Geneva.
  • 26
    World Health Organization (1997) Use DOT More Widely. WHO Report on the Tuberculosis Epidemic 1997. WHO/TB/97.224, Koninklijke van Poll Drukkerijen bv, Roosendaal.
  • 27
    World Health Organization (1999) What Is DOTS? A Guide to Understanding the WHO-recommended TB Control Strategy Known as DOTS. WHO/CDS/CPC/TB/99.270. WHO, Geneva.
  • 28
    World Health Organization (2001a) Global Tuberculosis Control. WHO Report 2001. WHO/CDS/TB/2001.287. WHO, Geneva.
  • 29
    World Health Organization (2001b) A Revised Framework for Effective Tuberculosis Control.http://www.stoptb.org/material/RevisedFramework.htm.
  • 30
    Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ & Tatley M (1998) Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 352 , 13401343.
  • 31
    Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ & Tatley M (2000) A randomised controlled trial of lay health workers as direct observer for treatment of tuberculosis. International Journal of Tuberculosis and Lung Disease 4 , 550554.